US Bancorp’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
2,643
+289
+12% +$122K ﹤0.01% 1098
2026
Q1
$889K Sell
2,354
-1,110
-32% -$475K ﹤0.01% 1207
2025
Q4
$1.48M Sell
3,464
-250
-7% -$109K ﹤0.01% 998
2025
Q3
$1.66M Buy
3,714
+279
+8% +$126K ﹤0.01% 947
2025
Q2
$1.67M Sell
3,435
-417
-11% -$238K ﹤0.01% 919
2025
Q1
$2.37M Sell
3,852
-277
-7% -$157K ﹤0.01% 788
2024
Q4
$2.19M Buy
4,129
+77
+2% +$43.4K ﹤0.01% 837
2024
Q3
$2.43M Sell
4,052
-72
-2% -$40.8K ﹤0.01% 796
2024
Q2
$2.24M Buy
4,124
+144
+4% +$82.5K ﹤0.01% 808
2024
Q1
$2.56M Sell
3,980
-5,256
-57% -$3.19M ﹤0.01% 758
2023
Q4
$5.4M Buy
9,236
+4,205
+84% +$2.35M 0.01% 553
2023
Q3
$2.61M Sell
5,031
-86
-2% -$44.7K ﹤0.01% 721
2023
Q2
$2.77M Sell
5,117
-196
-4% -$107K ﹤0.01% 702
2023
Q1
$2.86M Sell
5,313
-466
-8% -$238K ﹤0.01% 697
2022
Q4
$2.95M Sell
5,779
-762
-12% -$371K 0.01% 682
2022
Q3
$2.85M Sell
6,541
-618
-9% -$297K 0.01% 654
2022
Q2
$3.36M Sell
7,159
-3,677
-34% -$1.79M 0.01% 636
2022
Q1
$5.49M Buy
10,836
+349
+3% +$167K 0.01% 543
2021
Q4
$5.55M Buy
10,487
+190
+2% +$91.2K 0.01% 556
2021
Q3
$4.79M Sell
10,297
-1,514
-13% -$714K 0.01% 575
2021
Q2
$5.6M Buy
11,811
+255
+2% +$122K 0.01% 544
2021
Q1
$5.31M Buy
11,556
+538
+5% +$264K 0.01% 538
2020
Q4
$5.87M Buy
11,018
+755
+7% +$371K 0.01% 493
2020
Q3
$4.93M Sell
10,263
-717
-7% -$352K 0.01% 501
2020
Q2
$4.95M Sell
10,980
-2,068
-16% -$923K 0.01% 486
2020
Q1
$5.65M Buy
13,048
+17
+0.1% +$7.59K 0.02% 418
2019
Q4
$5.72M Sell
13,031
-241
-2% -$101K 0.01% 480
2019
Q3
$5.54M Sell
13,272
-1,794
-12% -$732K 0.02% 486
2019
Q2
$5.44M Sell
15,066
-814
-5% -$272K 0.02% 492
2019
Q1
$5.08M Sell
15,880
-761
-5% -$234K 0.01% 494
2018
Q4
$4.71M Sell
16,641
-114
-0.7% -$34.4K 0.02% 479
2018
Q3
$5.36M Buy
16,755
+376
+2% +$120K 0.02% 488
2018
Q2
$5.27M Buy
16,379
+577
+4% +$181K 0.02% 482
2018
Q1
$4.31M Sell
15,802
-210
-1% -$55.6K 0.01% 544
2017
Q4
$3.89M Buy
16,012
+169
+1% +$38.4K 0.01% 569
2017
Q3
$3.2M Buy
15,843
+147
+0.9% +$28.9K 0.01% 622
2017
Q2
$3.21M Sell
15,696
-1,524
-9% -$304K 0.01% 605
2017
Q1
$3.15M Sell
17,220
-485
-3% -$84.6K 0.01% 614
2016
Q4
$2.84M Buy
17,705
+1,701
+11% +$250K 0.01% 626
2016
Q3
$2.26M Sell
16,004
-2,160
-12% -$301K 0.01% 688
2016
Q2
$2.48M Sell
18,164
-817
-4% -$108K 0.01% 639
2016
Q1
$2.57M Sell
18,981
-1,553
-8% -$210K 0.01% 622
2015
Q4
$3.08M Sell
20,534
-637
-3% -$94.1K 0.01% 571
2015
Q3
$2.83M Buy
21,171
+331
+2% +$46.3K 0.01% 597
2015
Q2
$2.73M Sell
20,840
-421
-2% -$52.1K 0.01% 626
2015
Q1
$2.54M Sell
21,261
-168
-0.8% -$18.6K 0.01% 647
2014
Q4
$2.26M Buy
21,429
+388
+2% +$41K 0.01% 663
2014
Q3
$2.17M Sell
21,041
-6,808
-24% -$690K 0.01% 658
2014
Q2
$2.61M Buy
27,849
+642
+2% +$56.9K 0.01% 615
2014
Q1
$2.43M Buy
27,207
+2,496
+10% +$203K 0.01% 627
2013
Q4
$1.89M Buy
24,711
+246
+1% +$18.1K 0.01% 685
2013
Q3
$1.75M Buy
24,465
+112
+0.5% +$7.97K 0.01% 677
2013
Q2
$1.76M Buy
+24,353
New +$1.79M 0.01% 649

Other funds holding CHE

US Bancorp's CHE Position: Q2 2026 in Review

US Bancorp increased its Chemed (CHE) stake by 12% in Q2 2026, buying an estimated $122K and bringing the position to 2,643 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

US Bancorp first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.87M in Q4 2020. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • US Bancorp held 2,643 shares of Chemed worth $1.23M as of Q2 2026.
  • US Bancorp bought 289 Chemed shares in Q2 2026, an estimated $122K.
  • Chemed made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1098 holding.
  • US Bancorp first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's Chemed position peaked at $5.87M in Q4 2020.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.